Source Search Page
pmlive.com
Novo Nordisk and Valo Health expand alliance for cardiometabolic diseases
13+ hour, 36+ min ago —...North East England, Cumbria & Lancashire Sales Specialist, Diagnostic... ...Marcus Schindler, executive vice president and chief scientific officer...
pmlive.com
Eli Lilly’s Omvoh granted FDA approval to treat Crohn’s disease in adults
21+ hour, 34+ min ago —...Research Laboratories and Lilly Immunology, said: “People living... ...was recommended by the European Medicines Agency’s human medicines... ...North East England, Cumbria & Lancashire Sales Specialist, Diagnostic... ...Oncology - Southern England...
pmlive.com
Novartis’ investigational spinal muscular atrophy gene therapy shows promise in late-stage study
1+ week, 6+ day ago —...Shreeram Aradhye, president, development and chief medical officer... ...regulatory agencies, including the US Food and Drug Administration... ...- Devon & Cornwall Account Specialist - Respiratory - South West... ...- Oncology - Northern England & Yorkshire Account Specialist - Respiratory...
pmlive.com
Biogen/Eisai announce FDA BLA acceptance for injectable Alzheimer’s drug
1+ day, 13+ hour ago —...Biogen and Eisai have announced that the US Food and Drug Administration... ...recommended by the European Medicines Agency’s human medicines committee... ...- Devon & Cornwall Account Specialist - Respiratory - South West... ...- Oncology - Northern England & Yorkshire Account Specialist - Respiratory...
pmlive.com
AbbVie and Simcere to advance multiple myeloma candidate in partnership worth over $1bn
1+ day, 13+ hour ago —...Simcere Zaiming’s chief executive officer, Renhong Tang, added: “... ...Mariana Cota Stirner, vice president, therapeutic area head for haematology... ...- Devon & Cornwall Account Specialist - Respiratory - South West... ...- Oncology - Northern England & Yorkshire Account Specialist - Respiratory...
pmlive.com
Regeneron shares positive phase 3 results for Libtayo in high-risk skin cancer
1+ day, 13+ hour ago —...Drug Administration for Libtayo in this indication in the first... ...Israel Lowy, clinical development unit head, oncology, Regeneron,... ...- Devon & Cornwall Account Specialist - Respiratory - South West... ...- Oncology - Northern England & Yorkshire Account Specialist - Respiratory...
pmlive.com
Eli Lilly to acquire Scorpion’s solid tumour programme in deal worth $2.5bn
2+ day, 13+ hour ago —...Jacob Van Naarden, executive vice president and president of Lilly... ...Adam Friedman, Scorpion’s president and chief executive officer,...
pmlive.com
Eli Lilly and Alchemab Therapeutics partner to develop new ALS therapies
6+ day, 13+ hour ago —...Alchemab’s chief executive officer, Jane Osbourn, said the company... ...- Devon & Cornwall Account Specialist - Respiratory - South West...
pmlive.com
Sanofi announces positive phase 3 results for subcutaneous Sarclisa in multiple myeloma
3+ day, 13+ hour ago —...Houman Ashrafian, executive vice president, head of research and... ...The trial’s principal investigator, Sikander Ailawadhi, Mayo Clinic...
pmlive.com
Gilead and LEO enter inflammatory disease partnership worth up to $1.7bn
3+ day, 13+ hour ago —...Flavius Martin, executive vice president, research, Gilead, said... ...’s chief executive officer, Christophe Bourdon....